Terms: = Lung cancer AND FGFR1, CEK, 2260, ENSG00000077782, P11362, FLT2, CD331, H3, HBGFR, FGFBR, H5, KAL2, H2, BFGFR, N-SAM, H4
1076 results:
1. Discovery of the First-in-Class G9a/GLP PROTAC Degrader.
Velez J; Han Y; Yim H; Yang P; Deng Z; Park KS; Kabir M; Kaniskan HÜ; Xiong Y; Jin J
J Med Chem; 2024 Apr; 67(8):6397-6409. PubMed ID: 38602846
[TBL] [Abstract] [Full Text] [Related]
2. If it's a target, it's a pan-cancer target: Tissue is not the issue.
Adashek JJ; Kato S; Sicklick JK; Lippman SM; Kurzrock R
Cancer Treat Rev; 2024 Apr; 125():102721. PubMed ID: 38522181
[TBL] [Abstract] [Full Text] [Related]
3. Impact of Histone Lysine Methyltransferase SUV4-20H2 on cancer Onset and Progression with Therapeutic Potential.
Papadaki S; Piperi C
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473745
[TBL] [Abstract] [Full Text] [Related]
4. Hybrid epithelial-mesenchymal status of lung cancer dictates metastatic success through differential interaction with NK cells.
Parodi M; Centonze G; Murianni F; Orecchia P; Andriani F; Roato I; Gardelli C; Balsamo M; Moro M; Taiè G; Pastorino U; Petretto A; Lavarello C; Milione M; Sozzi G; Roz L; Vitale M; Bertolini G
J Immunother Cancer; 2024 Mar; 12(3):. PubMed ID: 38458638
[TBL] [Abstract] [Full Text] [Related]
5. OTUD4 promotes the progression of glioblastoma by deubiquitinating CDK1 and activating MAPK signaling pathway.
Ci M; Zhao G; Li C; Liu R; Hu X; Pan J; Shen Y; Zhang G; Li Y; Zhang L; Liang P; Cui H
Cell Death Dis; 2024 Mar; 15(3):179. PubMed ID: 38429268
[TBL] [Abstract] [Full Text] [Related]
6. Discovery of potent small molecule inhibitors of histone lysine methyltransferase NSDs.
Piao L; Gao Y; Xu X; Su Y; Wang YD; Zhou J; Gao Y; Fang J; Li Q; Chang S; Kong R
Eur J Med Chem; 2024 Mar; 268():116264. PubMed ID: 38412693
[TBL] [Abstract] [Full Text] [Related]
7. Diagnostic and prognostic value of serum soluble B7-H3 in nonsmall cell lung cancer.
Li Y; Xu L; Li J; Wang Q; Ma J
Anticancer Drugs; 2024 Jun; 35(5):426-432. PubMed ID: 38386015
[TBL] [Abstract] [Full Text] [Related]
8. NIPBL-mediated RAD21 facilitates tumorigenicity by the PI3K pathway in non-small-cell lung cancer.
Xu X; Wang D; Xu W; Li H; Chen N; Li N; Yao Q; Chen W; Zhong J; Mao W
Commun Biol; 2024 Feb; 7(1):206. PubMed ID: 38378967
[TBL] [Abstract] [Full Text] [Related]
9. Histone H3K36me3 mediates the genomic instability of Benzo[a]pyrene in human bronchial epithelial cells.
Chen S; Zhang Z; Peng H; Jiang S; Xu C; Ma X; Zhang L; Zhou H; Xing X; Chen L; Wang Q; Chen W; Li D
Environ Pollut; 2024 Apr; 346():123564. PubMed ID: 38367693
[TBL] [Abstract] [Full Text] [Related]
10. Spatial and temporal heterogeneity of tumor immune microenvironment between primary tumor and brain metastases in NSCLC.
Liu JS; Cai YX; He YZ; Xu J; Tian SF; Li ZQ
BMC Cancer; 2024 Jan; 24(1):123. PubMed ID: 38267913
[TBL] [Abstract] [Full Text] [Related]
11. circNINL facilitates aerobic glycolysis, proliferation, invasion, and migration in lung cancer by sponging miR-3918 to mediate fgfr1 expression.
Li S; Qiu C; Sun D; Yang S; Wang L
Eur J Med Res; 2024 Jan; 29(1):67. PubMed ID: 38245787
[TBL] [Abstract] [Full Text] [Related]
12. Biomarkers of peripheral blood neutrophil extracellular traps in the diagnosis and progression of malignant tumors.
Wang M; Lv X; Wang Y; Li Y; Li H; Shen Z; Zhao L
Cancer Med; 2024 Feb; 13(3):e6935. PubMed ID: 38230764
[TBL] [Abstract] [Full Text] [Related]
13. Disruption of LPA-LPAR1 pathway results in lung tumor growth inhibition by downregulating B7-H3 expression in fibroblasts.
Meng F; Yin Z; Lu F; Wang W; Zhang H
Thorac Cancer; 2024 Feb; 15(4):316-326. PubMed ID: 38124403
[TBL] [Abstract] [Full Text] [Related]
14. ADORA2A-driven proline synthesis triggers epigenetic reprogramming in neuroendocrine prostate and lung cancers.
Jing N; Zhang K; Chen X; Liu K; Wang J; Xiao L; Zhang W; Ma P; Xu P; Cheng C; Wang D; Zhao H; He Y; Ji Z; Xin Z; Sun Y; Zhang Y; Bao W; Gong Y; Fan L; Ji Y; Zhuang G; Wang Q; Dong B; Zhang P; Xue W; Gao WQ; Zhu HH
J Clin Invest; 2023 Dec; 133(24):. PubMed ID: 38099497
[TBL] [Abstract] [Full Text] [Related]
15. Exposure to nickel chloride induces epigenetic modification on detoxification enzyme glutathione S-transferase M2.
Kang YT; Yang WJ; Huang HC; Tang SC; Ko JL
Environ Toxicol; 2024 Mar; 39(3):1729-1736. PubMed ID: 38050843
[TBL] [Abstract] [Full Text] [Related]
16. Engineering CD276/B7-H3-targeted antibody-drug conjugates with enhanced cancer-eradicating capability.
Feng Y; Lee J; Yang L; Hilton MB; Morris K; Seaman S; Edupuganti VVSR; Hsu KS; Dower C; Yu G; So D; Bajgain P; Zhu Z; Dimitrov DS; Patel NL; Robinson CM; Difilippantonio S; Dyba M; Corbel A; Basuli F; Swenson RE; Kalen JD; Suthe SR; Hussain M; Italia JS; Souders CA; Gao L; Schnermann MJ; St Croix B
Cell Rep; 2023 Dec; 42(12):113503. PubMed ID: 38019654
[TBL] [Abstract] [Full Text] [Related]
17. Collision Enhanced Raman Scattering (CERS): An Ultra-High Efficient Raman Enhancement Technique for Hollow Core Photonic Crystal Fiber Based Raman Spectroscopy Gas Analyzer.
Shirmohammad M; Short MA; Zeng H
Biosensors (Basel); 2023 Nov; 13(11):. PubMed ID: 37998154
[TBL] [Abstract] [Full Text] [Related]
18. Epigenetic downregulation of O
Wang Z; Liu Z; Wang PS; Lin HP; Rea M; Kondo K; Yang C
Environ Pollut; 2024 Jan; 341():122978. PubMed ID: 37995958
[TBL] [Abstract] [Full Text] [Related]
19. Metabolic reprogramming driven by EZH2 inhibition depends on cell-matrix interactions.
W-M Fan T; Islam JMM; Higashi RM; Lin P; Brainson CF; Lane AN
J Biol Chem; 2024 Jan; 300(1):105485. PubMed ID: 37992808
[TBL] [Abstract] [Full Text] [Related]
20. Promoter-Specific Variants in NeuroD1 and H3K4me3 Coincident Regions and Clinical Outcomes of Small Cell lung cancer.
Yoo SS; Lee S; Choi JE; Hong MJ; Do SK; Lee JH; Lee WK; Park JE; Lee YH; Choi SH; Seo H; Lee J; Lee SY; Cha SI; Kim CH; Kang HG; Park JY
J Korean Med Sci; 2023 Nov; 38(45):e381. PubMed ID: 37987107
[TBL] [Abstract] [Full Text] [Related]
[Next]
